FDA Approves First At-Home STI Test For Women—How It Works And What You Need To Know
The FDA has approved the first at-home, nonprescription test for chlamydia, gonorrhea, and trichomoniasis in women. The Visby ...
FDA approves first at-home test to diagnose three STIs in women
The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic test for chlamydia, gonorrhea, and trichomoniasis in women, the agency ...
Health and Me on MSN23h
FDA Approves At-Home Test For Three STIs In Women
The US Food and Drug Administration has approved a single-use at-home test which can detect three STIs in women. Read on to ...
MPR1d
FDA Clears OTC Test for Chlamydia, Gonorrhea and Trichomoniasis
The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...
Sierra Sun Times2d
President Trump’s FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis
President Trump’s FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis ...
Clinical Advisor2d
Chlamydia Vaccine Candidate Gets Fast Track Status
The FDA has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.
FDA OKs first at-home test for 3 STIs
Visby Medical’s at-home diagnostic, which can be purchased without a prescription, tests for chlamydia, gonorrhea and ...
European Medical Journal2d
Sanofi’s chlamydia vaccine fast-tracked by FDA
This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.
MedPage Today5d
FDA OKs First At-Home Test for Chlamydia, Gonorrhea, and Trichomoniasis
The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and trichomoniasis in females. The so-called Visby Medical Women's Sexual Health Test ...
FDA authorizes Visby Medical’s home test for three STDs
The U.S. Food and Drug Administration (FDA) has granted marketing authorization to Visby Medical for its Women’s Sexual Health Test, the first home diagnostic test for chlamydia, gonorrhea, and ...
PharmExec5d
FDA Grants Fast Track Designation to Sanofi’s mRNA Chlamydia Vaccine
As part of the Fast Track designation, Sanofi is set to launch a Phase I/II trial to evaluate the immunogenicity and safety of its novel mRNA vaccine in preventing chlamydia.